» Authors » Eric Thouvenot

Eric Thouvenot

Explore the profile of Eric Thouvenot including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 144
Citations 1843
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thouvenot E, Laplaud D, Lebrun-Frenay C, Derache N, Le Page E, Maillart E, et al.
JAMA . 2025 Mar; PMID: 40063041
Importance: Vitamin D deficiency is a risk factor for multiple sclerosis (MS) and is associated with the risk of disease activity, but data on the benefits of supplementation are conflicting....
2.
De Seze J, Labauge P, Liblau R, Martinez M, Moreau T, Suchet L, et al.
Adv Ther . 2025 Feb; PMID: 39969782
Introduction: Dimethyl fumarate (DMF) has demonstrated a favorable benefit-risk profile in patients with relapsing-remitting multiple sclerosis (RRMS). Some patients may develop lymphopenia on DMF; therefore, LymphoTEC evaluated absolute lymphocyte count...
3.
Mainguy M, Casey R, Vukusic S, Lebrun-Frenay C, Berger E, Kerbrat A, et al.
Neurol Neuroimmunol Neuroinflamm . 2025 Feb; 12(2):e200371. PMID: 39933125
Background And Objectives: Older studies reported an increased risk of relapse after in vitro fertilization (IVF) in women with multiple sclerosis (MS), which has not been confirmed by more recent...
4.
Rodriguez S, Couloume L, Ferrant J, Vince N, Mandon M, Jean R, et al.
Front Immunol . 2025 Jan; 15():1494842. PMID: 39845960
Introduction: Myeloid cells trafficking from the periphery to the central nervous system are key players in multiple sclerosis (MS) through antigen presentation, cytokine secretion and repair processes. Methods: Combination of...
5.
Serghine Y, Laurent-Chabalier S, Thouvenot E, Parvu T, Renard D
Acta Neurol Belg . 2025 Jan; PMID: 39813005
Introduction: Radiological calcified cerebral embolism (CCE) characteristics have been reported in small case series. Our aim was to describe clinical and radiological CCE characteristics in a large number of CCE...
6.
Ramdani R, Pique J, Deschamps R, Ciron J, Maillart E, Audoin B, et al.
Mult Scler . 2025 Jan; 13524585241311435. PMID: 39812323
Background: The clinical course of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is variable. However, robust markers of poor outcome and/or relapse risk are still missing. Objective: To evaluate the...
7.
Durand-Dubief F, Shor N, Audoin B, Bourre B, Cohen M, Kremer S, et al.
J Neuroradiol . 2024 Dec; 52(1):101235. PMID: 39626832
Background: Currently, there are no available recommendations or guidelines on how to perform MRI monitoring in the management of neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease...
8.
Lefort M, Dejardin O, Berger E, Camdessanche J, Ciron J, Clavelou P, et al.
Mult Scler . 2024 Dec; 31(1):69-80. PMID: 39618051
Background: We hypothesized that differences in access to disease-modifying treatments (DMTs) could explain the association between socioeconomic status and disability progression in multiple sclerosis (MS). Objective: This study aimed to...
9.
Lefort M, Dejardin O, Berger E, Camdessanche J, Ciron J, Clavelou P, et al.
Mult Scler . 2024 Nov; 31(1):59-68. PMID: 39614776
Background: Studies have reported an association between socioeconomic status and disability progression in multiple sclerosis (MS), but findings using the pre-MS individual socioeconomic status are missing. Objective: The objective was...
10.
Salaun-Penquer E, Laurent-Chabalier S, Trandafir C, Cosma C, Parvu T, Wacongne A, et al.
J Stroke Cerebrovasc Dis . 2024 Nov; 34(1):108106. PMID: 39571666
Background: Pressure on carotid artery by hyoid bone may influence plaque formation. We studied CTA-based hyoid-carotid anatomical interaction and its relationship with carotid stenosis degree and stenosis-related stroke. Methods: We...